Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

The HLA-A2 restricted T cell epitope HCV core 35-44 stabilizes HLA-E expression and inhibits cytolysis mediated by natural killer cells.

Nattermann J, Nischalke HD, Hofmeister V, Ahlenstiel G, Zimmermann H, Leifeld L, Weiss EH, Sauerbruch T, Spengler U.

Am J Pathol. 2005 Feb;166(2):443-53.

2.

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.

Braud VM, Allan DS, O'Callaghan CA, Söderström K, D'Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier LL, McMichael AJ.

Nature. 1998 Feb 19;391(6669):795-9.

PMID:
9486650
3.

Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells.

Brooks AG, Borrego F, Posch PE, Patamawenu A, Scorzelli CJ, Ulbrecht M, Weiss EH, Coligan JE.

J Immunol. 1999 Jan 1;162(1):305-13.

4.

Peptides with dual binding specificity for HLA-A2 and HLA-E are encoded by alternatively spliced isoforms of the antioxidant enzyme peroxiredoxin 5.

Sensi M, Pietra G, Molla A, Nicolini G, Vegetti C, Bersani I, Millo E, Weiss E, Moretta L, Mingari MC, Anichini A.

Int Immunol. 2009 Mar;21(3):257-68. doi: 10.1093/intimm/dxn141. Epub 2009 Jan 30.

PMID:
19181932
5.

Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.

Mingari MC, Vitale C, Cantoni C, Bellomo R, Ponte M, Schiavetti F, Bertone S, Moretta A, Moretta L.

Eur J Immunol. 1997 Jun;27(6):1374-80.

PMID:
9209487
6.

Synergistic effect of IFN-gamma and human cytomegalovirus protein UL40 in the HLA-E-dependent protection from NK cell-mediated cytotoxicity.

Cerboni C, Mousavi-Jazi M, Wakiguchi H, Carbone E, Kärre K, Söderström K.

Eur J Immunol. 2001 Oct;31(10):2926-35.

PMID:
11592068
7.

HLA-E expression on porcine cells: protection from human NK cytotoxicity depends on peptide loading.

Forte P, Baumann BC, Weiss EH, Seebach JD.

Am J Transplant. 2005 Sep;5(9):2085-93.

8.

HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.

Pende D, Sivori S, Accame L, Pareti L, Falco M, Geraghty D, Le Bouteiller P, Moretta L, Moretta A.

Eur J Immunol. 1997 Aug;27(8):1875-80.

PMID:
9295021
9.

Cutting edge: expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1+Ly-49- cells: a possible mechanism of tolerance during NK cell development.

Sivakumar PV, Gunturi A, Salcedo M, Schatzle JD, Lai WC, Kurepa Z, Pitcher L, Seaman MS, Lemonnier FA, Bennett M, Forman J, Kumar V.

J Immunol. 1999 Jun 15;162(12):6976-80.

10.

The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1.

Pérez-Villar JJ, Melero I, Navarro F, Carretero M, Bellón T, Llano M, Colonna M, Geraghty DE, López-Botet M.

J Immunol. 1997 Jun 15;158(12):5736-43.

PMID:
9190923
11.

The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.

Della Chiesa M, Vitale M, Carlomagno S, Ferlazzo G, Moretta L, Moretta A.

Eur J Immunol. 2003 Jun;33(6):1657-66. Erratum in: Eur J Immunol. 2003 Oct;33(10):2947.

12.

Transgenic expression of HLA-E single chain trimer protects porcine endothelial cells against human natural killer cell-mediated cytotoxicity.

Lilienfeld BG, Crew MD, Forte P, Baumann BC, Seebach JD.

Xenotransplantation. 2007 Mar;14(2):126-34.

PMID:
17381687
13.

CD94/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.

Morel E, Escamochero S, Cabañas R, Díaz R, Fiandor A, Bellón T.

J Allergy Clin Immunol. 2010 Mar;125(3):703-10, 710.e1-710.e8. doi: 10.1016/j.jaci.2009.10.030. Epub 2010 Feb 4.

PMID:
20132973
14.

HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells.

King A, Allan DS, Bowen M, Powis SJ, Joseph S, Verma S, Hiby SE, McMichael AJ, Loke YW, Braud VM.

Eur J Immunol. 2000 Jun;30(6):1623-31.

16.

Natural killer cell recognition of HLA class I molecules.

Brooks AG, Boyington JC, Sun PD.

Rev Immunogenet. 2000;2(3):433-48. Review.

PMID:
11256749
17.

Influence of Hsp70 and HLA-E on the killing of leukemic blasts by cytokine/Hsp70 peptide-activated human natural killer (NK) cells.

Stangl S, Gross C, Pockley AG, Asea AA, Multhoff G.

Cell Stress Chaperones. 2008 Summer;13(2):221-30. doi: 10.1007/s12192-007-0008-y. Epub 2008 Feb 26.

18.

Increased frequency of human leukocyte antigen-E inhibitory receptor CD94/NKG2A-expressing peritoneal natural killer cells in patients with endometriosis.

Galandrini R, Porpora MG, Stoppacciaro A, Micucci F, Capuano C, Tassi I, Di Felice A, Benedetti-Panici P, Santoni A.

Fertil Steril. 2008 May;89(5 Suppl):1490-6. Epub 2007 Aug 13.

PMID:
17706207
19.

The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells.

Gumá M, Busch LK, Salazar-Fontana LI, Bellosillo B, Morte C, García P, López-Botet M.

Eur J Immunol. 2005 Jul;35(7):2071-80. Erratum in: Eur J Immunol. 2005 Jul;35(7):2259.

20.

An HLA-E single chain trimer inhibits human NK cell reactivity towards porcine cells.

Crew MD, Cannon MJ, Phanavanh B, Garcia-Borges CN.

Mol Immunol. 2005 Jun;42(10):1205-14. Epub 2005 Jan 8.

PMID:
15829309

Supplemental Content

Support Center